The development of vaccines against SARS-CoV-2 has proceeded at an unprecedented pace, resulting in emergency use approvals and accelerated deployment of multiple vaccines. This development and deployment has occurred within a year of the Public Health Emergency of International Concern declaration by WHO. However, some attempts to develop vaccines have run into difficulties in early clinical development.